IP Library Granted Patent US 7,037,521
Granted Patent B2
US 7,037,521 · App. 10/402,355 · Granted May 2, 2006

Using a laser for cutting a hole in a capsule for controlled drug delivery

Assignee: Bausch & Lomb Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,037,521
App. No.
10/402,355
Granted
May 2, 2006
Kind
B2
Abstract

A method of fabricating capsules for sustained and controlled drug delivery. An array of capsules of a hydrophobic polymer is subjected to an extraction process to remove low-molecular-weight monomers, oligomers and polymers, and a laser is used to open accurately sized, spaced, and shaped holes in the capsules. In the process, the laser cutting oxidizes the hydrophobic polymer, making it sufficiently hydrophilic to allow wetting by the contents of the capsules. The capsules are then filled with a hydrophilic polymer covering the laser-cut opening and with one or more drugs for delivery, sealed, and removed from the array for mounting on suture tabs or other mounts. The use of the laser helps insure accurate and reliable delivery of drugs from the capsule.

Claims (50)

1. A method of cutting a hole in a capsule for controlled drug delivery, comprising the steps of:

fabricating an array of capsules made of a first hydrophobic polymer and having a large first opening;

extracting low-molecular-weight components from the first hydrophobic polymer;

using a laser to cut one or more second openings of uniform size, shape, and position in each capsule, and to oxidize the first hydrophobic polymer;

fabricating individual drug-filled capsules from the array of capsules having laser-cut second openings wherein the first hydrophibic polymer is polydimethyl siloxane (PDMS).

2. The method of claim 1 , wherein the step of fabricating individual drug-filled capsules from the array of capsules having laser-cut holes further comprises the steps of:

placing a hydrophilic polymer to cover the one or more second openings in each capsule via the large first opening;

placing one or more drugs in each capsule to cover the hydrophilic polymer via the large first opening;

placing a second hydrophobic polymer to cover the drug via the large first opening, thereby closing off the large first opening;

bonding the second hydrophobic polymer to the first hydrophobic polymer;

cutting the array of capsules apart to produce individual drug-filled capsules.

3. The method of claim 2 , wherein the step of placing a hydrophilic polymer to cover the one or more second openings in each capsule via the large first opening comprises the step of placing polyvinyl alcohol (PVA) to cover the one or more second openings in each capsule via the large first opening.

4. The method of claim 2 , wherein the second hydrophobic polymer is polydimethyl siloxane.

5. The method of claim 1 , wherein the step of fabricating individual drug-filled capsules from the array of capsules having laser-cut holes further comprises the steps of:

placing one or more drugs in each capsule to cover the one or more second openings via the large first opening;

placing a hydrophilic polymer to cover the drug in each capsule via each of the one or more second openings;

placing a second hydrophobic polymer to cover the drug via the large first opening, thereby closing off the large first opening;

bonding the second hydrophobic polymer to the first hydrophobic polymer;

cutting the array of capsules apart to produce individual drug-filled capsules.

6. The method of claim 5 , wherein the step of placing a hydrophilic polymer to cover the one or more second openings in each capsule via the large first opening comprises the step of placing polyvinyl alcohol (PVA) to cover the one or more second openings in each capsule via the large first opening.

7. The method of claim 5 , wherein the second hydrophobic polymer is polydimethyl siloxane.

8. The method of claim 1 , wherein the step of fabricating individual drug-filled capsules from the array of capsules having laser-cut holes further comprises the steps of:

placing a hydrophilic polymer combined with one or more drugs to cover the one or more second openings in each capsule via the large first opening;

placing a second hydrophobic polymer to cover the hydrophilic polymer and drug via the large first opening, thereby closing off the large first opening;

bonding the second hydrophobic polymer to the first hydrophobic polymer;

cutting the array of capsules apart to produce individual drug-filled capsules.

9. The method of claim 8 , wherein the step of placing a hydrophilic polymer combined with one or more drugs to cover the one or more second openings in each capsule via the large first opening comprises the step of placing polyvinyl alcohol (PVA) combined with one or more drugs to cover the one or more second openings in each capsule via the large first opening.

10. The method of claim 8 , wherein the second hydrophobic polymer is polydimethyl siloxane.

11. A method of fabricating a drug-delivery capsule for controlled delivery of one or more drugs, comprising the steps of:

fabricating an array of capsules made of a first hydrophobic polymer and having a large first opening;

extracting low-molecular-weight components from the first hydrophobic polymer;

using a laser to cut one or more second openings of uniform size, shape, and position in each capsule, and to oxidize the first hydrophobic polymer;

fabricating individual drug-filled capsules from the array of capsules having laser-cut second openings;

attaching a suture tab to each individual drug-filled capsule wherein the first hydrophobic polymer is polydimethyl siloxane (PDMS).

12. The method of claim 11 , wherein the step of fabricating individual drug-filled capsules from the array of capsules having laser-cut holes further comprises the steps of:

placing a hydrophilic polymer to cover the one or more second openings in each capsule via the large first opening;

placing one or more drugs in each capsule to cover the hydrophilic polymer via the large first opening;

placing a second hydrophobic polymer to cover the drug via the large first opening, thereby closing off the large first opening;

bonding the second hydrophobic polymer to the first hydrophobic polymer;

cutting the array of capsules apart to produce individual drug-filled capsules.

13. The method of claim 12 , wherein the step of placing a hydrophilic polymer to cover the one or more second openings in each capsule via the large first opening comprises the step of placing polyvinyl alcohol (PVA) to cover the one or more second openings in each capsule via the large first opening.

14. The method of claim 12 , wherein the second hydrophobic polymer is polydimethyl siloxane.

15. The method of claim 11 , wherein the step of fabricating individual drug-filled capsules from the array of capsules having laser-cut holes further comprises the steps of:

placing one or more drugs in each capsule to cover the one or more second openings via the large first opening;

placing a hydrophilic polymer to cover the drug in each capsule via each of the one or more second openings;

placing a second hydrophobic polymer to cover the drug via the large first opening, thereby closing off the large first opening;

bonding the second hydrophobic polymer to the first hydrophobic polymer;

cutting the array of capsules apart to produce individual drug-filled capsules.

16. The method of claim 15 , wherein the step of placing a hydrophilic polymer to cover the one or more second openings in each capsule via the large first opening comprises the step of placing polyvinyl alcohol (PVA) to cover the one or more second openings in each capsule via the large first opening.

17. The method of claim 15 , wherein the second hydrophobic polymer is polydimethyl siloxane.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Mar 26, 2008
From: BAUSCH & LOMB INCORPORATED; WP PRISM INC.; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; IOLAB CORPORATION; RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC
To: CREDIT SUISSE
Reel/Frame 020733/0765 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2003
From: MOSACK, LINDA
To: BAUSCH & LOMB, INCORPORATED
Reel/Frame 014219/0288 →
Continuity (1)
Related Publication 20040191308A1 · Sep 30, 2004